MDK_MINIBINDERS - Validation of artificial intelligence-based minibinders and inhibitors of Midkine in immune resistant tumours
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
This proposal aims to validate artificial intelligence (AI)-designed minibinders and blockers of the growth factor Midkine (MDK) as anticancer agents to bypass resistance to current immunotherapies. The rationale stems from reports by our laboratory in Nature, Nature Medicine...